• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食失调患者的药物治疗。

Drug therapy for patients with eating disorders.

作者信息

Mitchell J E, de Zwaan M, Roerig J L

机构信息

The Neuropsychiatric Research Institute, 700 1st Avenue So., P.O. Box 1415, Fargo, ND 58107, USA.

出版信息

Curr Drug Targets CNS Neurol Disord. 2003 Feb;2(1):17-29. doi: 10.2174/1568007033338850.

DOI:10.2174/1568007033338850
PMID:12769809
Abstract

The purpose of this article is to review the psychopharmacology treatment literature for patients with eating disorders including bulimia nervosa, anorexia nervosa and binge eating disorder. The best-developed treatment literature concerns bulimia nervosa, which has been studied now in several dozen pharmacological treatment studies. The agents most commonly used are the antidepressants, with particular focus on the selective serotonin reuptake inhibitors including fluoxetine hydrochloride. These agents clearly impact significantly on the frequency of abnormal eating behaviors such as binge eating and purging. However, subjects treated with these drugs rarely achieve remission. Pharmacotherapy of anorexia nervosa has also traditionally focused on the use of antidepressants and there is some evidence that the use of SSRIs may help in preventing relapse in weight restored patients. Recently interest has developed in the use of atypical neuroleptics to help with the obsessionality and resistance to treatment frequently seen in low weight patients, the most commonly employed agent being olanzapine. Pharmacotherapy of binge-eating disorder is now being intensively investigated. In general medication alone seems inferior to psychotherapy in the short term. Antidepressants can increase the amount of weight loss when combined with psychological treatment and also appear to benefit symptoms such as depression. Further data are needed, but a number of drugs appear promising.

摘要

本文旨在综述针对饮食失调患者(包括神经性贪食症、神经性厌食症和暴饮暴食症)的精神药理学治疗文献。目前研究最为充分的治疗文献涉及神经性贪食症,现已开展了几十项药物治疗研究。最常用的药物是抗抑郁药,尤其侧重于选择性5-羟色胺再摄取抑制剂,包括盐酸氟西汀。这些药物对暴饮暴食和催吐等异常饮食行为的频率有显著影响。然而,接受这些药物治疗的患者很少能实现缓解。传统上,神经性厌食症的药物治疗也侧重于使用抗抑郁药,有证据表明,使用选择性5-羟色胺再摄取抑制剂可能有助于防止体重恢复的患者复发。最近,人们开始关注使用非典型抗精神病药来帮助解决体重过低患者常见的强迫观念和治疗抵抗问题,最常用的药物是奥氮平。暴饮暴食症的药物治疗目前正在深入研究中。一般来说,短期内单独使用药物似乎不如心理治疗。抗抑郁药与心理治疗联合使用时可增加体重减轻量,而且似乎对抑郁等症状也有帮助。还需要更多数据,但一些药物看起来很有前景。

相似文献

1
Drug therapy for patients with eating disorders.饮食失调患者的药物治疗。
Curr Drug Targets CNS Neurol Disord. 2003 Feb;2(1):17-29. doi: 10.2174/1568007033338850.
2
Evidence-based pharmacotherapy of eating disorders.基于证据的进食障碍药物治疗。
Int J Neuropsychopharmacol. 2012 Mar;15(2):189-207. doi: 10.1017/S1461145711000381. Epub 2011 Mar 18.
3
The use of selective serotonin reuptake inhibitors in eating disorders.选择性5-羟色胺再摄取抑制剂在饮食失调症中的应用。
J Clin Psychiatry. 1998;59 Suppl 15:28-34.
4
Towards the pharmacotherapy of eating disorders.迈向饮食失调的药物治疗。
Expert Opin Pharmacother. 2003 Oct;4(10):1659-78. doi: 10.1517/14656566.4.10.1659.
5
Clinical psychopharmacology of eating disorders: a research update.进食障碍的临床精神药理学:研究进展。
Int J Neuropsychopharmacol. 2012 Mar;15(2):209-22. doi: 10.1017/S1461145711000460. Epub 2011 Mar 25.
6
Biological therapies for eating disorders.进食障碍的生物治疗。
Int J Eat Disord. 2013 Jul;46(5):470-7. doi: 10.1002/eat.22104.
7
Emerging drugs for eating disorder treatment.用于治疗饮食失调的新型药物。
Expert Opin Emerg Drugs. 2006 May;11(2):315-36. doi: 10.1517/14728214.11.2.315.
8
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.世界生物精神病学学会联合会(WFSBP)进食障碍药物治疗指南。
World J Biol Psychiatry. 2011 Sep;12(6):400-43. doi: 10.3109/15622975.2011.602720.
9
Psychosocial and pharmacological treatment of eating disorders: a review of research findings.饮食失调的心理社会及药物治疗:研究结果综述
J Clin Psychol. 1999 Jun;55(6):685-97. doi: 10.1002/(sici)1097-4679(199906)55:6<685::aid-jclp3>3.0.co;2-y.
10
Pharmacotherapy of eating disorders.饮食失调的药物治疗。
Curr Opin Psychiatry. 2017 Nov;30(6):452-457. doi: 10.1097/YCO.0000000000000358.

引用本文的文献

1
Revealing the effects of various immune cells in anorexia nervosa: Evidence from Mendelian randomization.揭示各种免疫细胞在神经性厌食症中的作用:来自孟德尔随机化的证据。
Medicine (Baltimore). 2025 Mar 21;104(12):e41817. doi: 10.1097/MD.0000000000041817.
2
Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.急性或重复给予帕罗西汀和氟西汀对雄性和雌性青春期大鼠情感行为的影响。
Psychopharmacology (Berl). 2015 Oct;232(19):3515-28. doi: 10.1007/s00213-015-4003-1. Epub 2015 Jul 5.
3
Is deep brain stimulation a treatment option for anorexia nervosa?
深部脑刺激是神经性厌食症的一种治疗选择吗?
BMC Psychiatry. 2013 Oct 31;13:277. doi: 10.1186/1471-244X-13-277.
4
A randomized controlled comparison of integrative cognitive-affective therapy (ICAT) and enhanced cognitive-behavioral therapy (CBT-E) for bulimia nervosa.一项针对神经性贪食症的综合认知情感疗法(ICAT)与强化认知行为疗法(CBT-E)的随机对照比较。
Psychol Med. 2014 Feb;44(3):543-53. doi: 10.1017/S0033291713001098. Epub 2013 May 23.
5
Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders.回顾性图表审查参考脑电图数据库,以协助选择治疗饮食障碍患者抑郁症的药物。
Neuropsychiatr Dis Treat. 2011;7:529-41. doi: 10.2147/NDT.S22271. Epub 2011 Sep 9.
6
Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.帕金森病中多巴胺能治疗的行为不良反应:发生率、神经生物学基础、管理与预防
Drug Saf. 2009;32(6):475-88. doi: 10.2165/00002018-200932060-00004.
7
De-stabilization of the positive vago-vagal reflex in bulimia nervosa.神经性贪食症中正向迷走-迷走反射的失稳
Physiol Behav. 2008 Apr 22;94(1):136-53. doi: 10.1016/j.physbeh.2007.11.036. Epub 2007 Nov 28.
8
The psychopharmacotherapy of anorexia nervosa: clinical, neuroendocrine and metabolic aspects.神经性厌食症的心理药物治疗:临床、神经内分泌和代谢方面。
J Endocrinol Invest. 2004 Nov;27(10):975-81. doi: 10.1007/BF03347545.